Recent Company News

• 07:48 AM ET Mar 25, 2025
  

  Burning Rock Biotech reports Q4 EPS (CNY0.79) vs year-ago (CNY1.58) ($5.50, 0.00)

• 12:02 AM ET Dec 04, 2024
  

  Burning Rock Biotech reports Q3 EPS (CNY0.05) vs year-ago (CNY1.71) ($6.10, 0.00)

• 11:24 PM ET Oct 10, 2024
  

  NMPA approves Burning Rock Biotech-Dizal Pharma's CDx for EGFR for sunvozertinib

• 08:39 AM ET Sep 27, 2024
  

  Burning Rock Biotech CFO Leo Li; effective 27-Sep ($3.39, 0.00)

• 12:04 AM ET Aug 23, 2024
  

  Burning Rock Biotech reports Q2 EPS (CNY1.05) vs year-ago (CNY1.28) ($6.44, 0.00)

• 02:12 AM ET Aug 19, 2024
  

  Burning Rock Biotech seeks delisting and cancellation of admission to trading of its ADSs from LSE

• 04:01 AM ET May 29, 2024
  

  CORRECTION: Burning Rock Biotech reports Q1 EPS (CNY1.19) vs year-ago (CNY1.81) ($7.55, 0.00)

• 01:47 AM ET May 29, 2024
  

  Burning Rock Biotech reports Q1 EPS (CNY0.16) vs year-ago (CNY1.81) ($7.55, 0.00)

• 02:01 AM ET May 14, 2024
  

  Burning Rock Biotech ADR ratio change to become effective tomorrow ($0.81, 0.00)